S11E1077 New ASAM Guidelines for Ethanol Withdrawal | GameChangers
Ethanol use disorder continues to be a major problem in the U.S. The stress and anxiety related to the COVID-19 pandemic… More Details
Stay connected to the latest clinical updates, teaching strategies, and practice-ready skills – delivered in a format that fits your busy life. Learn on your schedule without sacrificing quality or depth.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update Series is included with your Pharmacist Subscription. But wait…there’s even more!
What the Pharmacist CE Subscription Includes:
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
Ethanol use disorder continues to be a major problem in the U.S. The stress and anxiety related to the COVID-19 pandemic… More Details
Geoff Wall, PharmD delivers another great podcast. Pharmacists see skeletal muscle relaxant prescriptions daily but how much real experience do we have… More Details
Overinflamation or cytokine storm is said to be the driver of acute respiratory disorder disease (ARDS) in COVID patients. A… More Details
The COVID-19 pandemic has disproportionally affected Latinx Americans. Learn how pharmacists can optimize patient care for Latinx patients by discussing how… More Details
Many patients over age 65 take daily medications that have anticholinergic properties. We know the addition of these drugs can… More Details
The American College of Rheumatology recently published new guidelines for the treatment of Gout. While gout is well understood and… More Details
Racism is a public health emergency and a root cause of social determinants of health. If we are to practice… More Details
Recently news suggests low vitamin D levels have been associated with increased risk of COVID-related morbidity and mortality. We know… More Details
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in… More Details
Buprenorphine has been shown in numerous studies to be safe and effective in opioid use disorder, yet < 10% patients… More Details
Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption… More Details
GameChangers: In this episode, we describe the latest information concerning hypercoagulability with COVID-19 infection. In this episode, we describe the… More Details